atenolol has been researched along with Reperfusion Injury in 8 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A series of aminoalkanolic derivatives of xanthone with high affinity for β1-adrenoceptors was evaluated for antiarrhythmic activity in the model of ischemia-reperfusion in isolated hearts, as well as in barium chloride- and adrenaline-induced model of arrhythmia." | 3.80 | Antiarrhythmic activity of some xanthone derivatives with β1-adrenoceptor affinities in rats. ( Bednarski, M; Filipek, B; Marona, H; Rapacz, A; Sapa, J; Szkaradek, N, 2014) |
| " In the remaining 8 swine, atenolol was infused after 10-min ischemia at a dosage [mean 1." | 1.29 | Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol. ( Heusch, G; Rose, J; Schulz, R; Skyschally, A, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okada, M | 1 |
| Falcão, LFR | 1 |
| Ferez, D | 1 |
| Martins, JL | 1 |
| Errante, PR | 1 |
| Rodrigues, FSM | 1 |
| Caricati-Neto, A | 3 |
| Marinho, M | 1 |
| Fenelon, G | 1 |
| Oliveira-Júnior, IS | 2 |
| Taha, MO | 3 |
| Silva, TMAE | 1 |
| Ota, KS | 1 |
| Vilela, WJ | 1 |
| Simões, RS | 2 |
| Starzewski Junior, A | 1 |
| Fagundes, DJ | 2 |
| Rapacz, A | 1 |
| Sapa, J | 1 |
| Bednarski, M | 1 |
| Filipek, B | 1 |
| Szkaradek, N | 1 |
| Marona, H | 1 |
| Öztürk, T | 1 |
| Vural, K | 1 |
| Tuğlu, İ | 1 |
| Var, A | 1 |
| Kurdal, T | 1 |
| Aydemir, I | 1 |
| Miranda-Ferreira, R | 2 |
| Oliveira, I | 1 |
| Modaelli-Filho, ML | 1 |
| Magalhães-Junior, WF | 1 |
| Souza, ES | 1 |
| Lemos, JA | 1 |
| Simões, MC | 1 |
| Campos, VF | 1 |
| Taha, NS | 1 |
| Teixeira, GD | 1 |
| Souza, WT | 1 |
| Carmo, CE | 1 |
| Silva-Neto, LA | 1 |
| Gomes, IT | 1 |
| Monteiro, HP | 1 |
| Montero, EF | 1 |
| Bhatt, LK | 1 |
| Nandakumar, K | 1 |
| Bodhankar, SL | 1 |
| Bansal, J | 1 |
| Piplani, P | 1 |
| Schulz, R | 1 |
| Rose, J | 1 |
| Skyschally, A | 1 |
| Heusch, G | 1 |
8 other studies available for atenolol and Reperfusion Injury
| Article | Year |
|---|---|
Effect of atenolol pre-treatment in heart damage in a model of intestinal ischemia-reperfusion.
Topics: Animals; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Heart; Intestines; Male; Mesent | 2017 |
The role of atenolol in the modulation of the expression of genes encoding pro- (caspase-1) and anti- (Bcl2L1) apoptotic proteins in endothelial cells exposed to intestinal ischemia and reperfusion in rats.
Topics: Animals; Apoptosis; Atenolol; bcl-X Protein; Caspase 1; Constriction; Cytoprotection; Down-Regulatio | 2018 |
Antiarrhythmic activity of some xanthone derivatives with β1-adrenoceptor affinities in rats.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Arrhythmias, Cardiac; Atenolol; Barium Compounds; Chl | 2014 |
Acute and Chronic Pretreatment With Atenolol Attenuates Intestinal Ischemia and Reperfusion Injury in Hypercholesterolemic Rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Apoptosis; Atenolol; Disease Models, Animal; Hyperc | 2016 |
Intestinal ischemia-reperfusion is attenuated by treatment with atenolol in rabbits.
Topics: Animals; Atenolol; Blood Circulation; Electric Stimulation; Intestinal Diseases; Intestines; Jejunum | 2010 |
Atenolol to treat intestinal ischemia and reperfusion in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Atenolol; Cytoprotection; Disease Models, Animal; E | 2012 |
Beta-blocking activity of PP-34, a newly synthesized aryloxypropanolamine derivative, and its cardioprotective effect against ischaemia/reperfusion injury in laboratory animals.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atenolol; Benzylamines; Female; Guinea P | 2007 |
Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol.
Topics: Adenosine Triphosphate; Animals; Atenolol; Benzazepines; Blood Pressure; Bradycardia; Cardiovascular | 1995 |